---
title: "Depressive Symptoms Linked to Higher Prevalent Cardiovascular Disease in Urban Haiti"
id: "medrxiv-16-depressive-symptoms-and-prevalent-cardiovascular-disease-a-cross-sectional"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-16-depressive-symptoms-and-prevalent-cardiovascular-disease-a-cross-sectional"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.07.15.26358073v1?rss=1"
published_at: "2026-07-18T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Depressive Symptoms Linked to Higher Prevalent Cardiovascular Disease in Urban Haiti
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-16-depressive-symptoms-and-prevalent-cardiovascular-disease-a-cross-sectional
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.07.15.26358073v1?rss=1)
- **Published At:** 2026-07-18T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Cross-sectional analysis of 2,995 adults enrolled in the Haiti Cardiovascular Disease Cohort (March 2019–August 2021) examined the association between **depressive symptoms** and prevalent **cardiovascular disease (CVD)** in Port‑au‑Prince, Haiti. - Depressive symptoms (DS) were measured with the **Patient Health Questionnaire–9 (PHQ‑9)** and categorized as none–mild (PHQ‑9 <10) versus moderate–severe (PHQ‑9 ≥10). - Prevalent CVD included angina, myocardial infarction, transient ischemic attack or stroke, and heart failure adjudicated using epidemiologic definitions aligned with international cohorts. - Overall, 16.2% of participants (n=484) had moderate–severe DS; prevalence was higher in females (22.0%) than males (8.5%). - CVD prevalence was greater among participants with moderate–severe DS compared with none–mild DS for both sexes (males: 21.5% vs 10.6%; females: 23.3% vs 15.3%). - In adjusted models controlling for age, sex, education, income, food insecurity, smoking, alcohol use, physical activity, stress, and BMI, moderate–severe DS were associated with higher CVD prevalence (adjusted prevalence ratio [aPR] = 1.36; 95% CI: 1.08–1.71). - Sex-stratified adjusted estimates were aPR 1.38 (95% CI: 1.06–1.78) for females and aPR 1.25 (95% CI: 0.75–1.99) for males; formal evidence for interaction by sex on the additive scale was limited (RERI = 0.07; 95% CI: −0.74 to 0.88). - Authors conclude moderate–severe DS are independently associated with higher prevalent CVD in urban Haiti; associations appeared stronger among women though sex effect modification was not clearly demonstrated. - The report is a preprint not yet peer reviewed; authors recommend integrating depression screening and management into CVD prevention in resource‑limited settings and call for prospective studies to clarify causal pathways and mechanisms. - Ethical approvals and informed consent were obtained; study funded in part by NIH (R01HL143788).
## Clinical Analysis & Structured Key Points
Skip to main content HOMESUBMITFAQBLOGALERTS / RSSRESOURCESABOUT Search for this keyword Advanced Search Follow this preprint Depressive Symptoms and Prevalent Cardiovascular Disease: A Cross-Sectional Analysis in Port-au-Prince, Haiti Daniella Myriam Pierre, Rehana Rasul, Reichling St. Sauveur, Kelly Celestin, Vanessa Rouzier, Erline Hilaire, Marie Marcelle Deschamps, Jean William Pape, Lily D. Yan, Anju Ogyu, Catherine Bennett, Margaret L. McNairy, Rodney Sufra, Denis Nash doi: https://doi.org/10.64898/2026.07.15.26358073 This article is a preprint and has not been certified by peer review [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice. AbstractInfo/HistoryMetrics Preview PDF Abstract Background: Cardiovascular disease (CVD) is the leading cause of mortality in low- and middle-income countries (LMICs). In Haiti, depression remains an underexplored CVD risk factor. We assessed the association between depressive symptoms (DS) and prevalent CVD in urban Haiti and examined sex differences. Methods: We conducted a cross-sectional analysis of enrollment data from the Haiti Cardiovascular Disease Cohort (adults ≥18 years; March 2019—August 2021). DS were measured using the Patient Health Questionnaire–9 (PHQ–9) and categorized as none—mild (<10) versus moderate—severe (≥10). Prevalent CVD (angina, myocardial infarction, transient ischemic attack or stroke, heart failure) was adjudicated using epidemiologic definitions aligned with international cohorts. We estimated prevalence ratios (PRs) using generalized estimating equation Poisson models with a log link, adjusting for age, sex, education, income, food insecurity, smoking, alcohol use, physical activity, stress, and BMI. Effect modification by sex was assessed on multiplicative and additive scales. Results: Among 2,995 participants (mean age 41.9 years; 58.0% female), 16.2% (95% CI: 14.8-17.5; n=484) had moderate—severe DS. Prevalence was higher in females (22.0%, 95% CI: 19.8–23.6) than males (8.5%, 95% CI: 7.0–10.1). The prevalence of CVD was higher among participants with moderate—severe DS compared with those with none—mild DS, with similar patterns observed in both sexes (males: 21.5% vs 10.6%; females: 23.3% vs 15.3%). Moderate—severe DS were associated with higher CVD prevalence compared with none—mild DS (adjusted PR [aPR]=1.36; 95% CI: 1.08—1.71). In sex-stratified models, aPRs were 1.38 (95% CI: 1.06—1.78) for females and 1.25 (95% CI: 0.75—1.99) for males. Evidence for interaction by sex on the additive scale was limited (RERI=0.07, 95% CI: −0.74 to 0.88). Conclusion: Moderate—severe DS were independently associated with a higher prevalence of CVD in urban Haiti. Associations were consistently stronger among women, although evidence for effect modification by sex was limited. Integrating depression screening and management into CVD prevention efforts may help address the growing burden of both conditions in resource–limited settings. Prospective studies are warranted to better understand the underlying mechanisms and causal pathways. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Before enrollment, all participants provided written informed consent. The Institutional Review Board of Weill Cornell Medicine and the Ethics Committee of Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO) approved this research. The study also received input from community stakeholders and the GHESKIO Community Advisory Board prior to initiation. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes FUNDER INFORMATION DECLARED National Institutes of Health, https://ror.org/01cwqze88, R01HL143788 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license. bioRxiv and medRxiv thank the following for their generous financial support: The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. Donate to openRxiv Back to top Previous Next Posted July 18, 2026. Download PDF Print/Save Options Author Declarations Supplementary Material Data/Code Email Share Citation Tools Get QR code Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos Subject Areas All Articles Addiction Medicine Allergy and Immunology Anesthesia Cardiovascular Medicine Dentistry and Oral Medicine Dermatology Emergency Medicine Endocrinology (including Diabetes Mellitus and Metabolic Disease) Epidemiology Forensic Medicine Gastroenterology Genetic and Genomic Medicine Geriatric Medicine Health Economics Health Informatics Health Policy Health Systems and Quality Improvement Hematology HIV/AIDS Infectious Diseases (except HIV/AIDS) Intensive Care and Critical Care Medicine Medical Education Medical Ethics Nephrology Neurology Nursing Nutrition Obstetrics and Gynecology Occupational and Environmental Health Oncology Ophthalmology Orthopedics Otolaryngology Pain Medicine Palliative Medicine Pathology Pediatrics Pharmacology and Therapeutics Primary Care Research Psychiatry and Clinical Psychology Public and Global Health Radiology and Imaging Rehabilitation Medicine and Physical Therapy Respiratory Medicine Rheumatology Sexual and Reproductive Health Sports Medicine Surgery Toxicology Transplantation Urology Evaluation/discussion of this paper x 0 0 0 0 0 0 We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. Continue Find out more
## Related Clinical Research

- [Multimodal extraction of heart disease risk factors from free-text and structured records using Li](https://medichelpline.com/clinical-feed/plos-one-0-leveraging-free-text-clinical-records-for-heart-disease-classification-through.md)
- [Long-term cardiovascular risk after assisted reproductive technology and infertility: nationwide c](https://medichelpline.com/clinical-feed/plos-medicine-0-long-term-risk-of-cardiovascular-disease-after-assisted-reproductive-technology.md)
- [Cardiometabolic pathways mediating the effect of educational attainment on cardiovascular disease:](https://medichelpline.com/clinical-feed/medrxiv-13-cardiometabolic-pathways-linking-genetically-proxied-educational-attainment-to.md)
- [Pre-diagnostic 1-year prevalence of polypharmacy and PIMcog in Norwegian outpatients with MCI or d](https://medichelpline.com/clinical-feed/plos-one-14-one-year-pre-diagnostic-prevalence-and-associated-factors-of-polypharmacy-and.md)
- [Semaglutide and Primary Prevention of MACCE in Obese Adults with T2DM and Rheumatoid Arthritis](https://medichelpline.com/clinical-feed/pubmed-42334436.md) (DOI: 10.1093/ehjcvp/pvag044)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.